BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]